V013-5057 Screening compound: N-[4-(4-acetylpiperazine-1-carbonyl)-1,3-thiazol-2-yl]-2-fluorobenzamide

V013-5057 Screening compound: N-[4-(4-acetylpiperazine-1-carbonyl)-1,3-thiazol-2-yl]-2-fluorobenzamide
V013-5057 Screening compound: N-[4-(4-acetylpiperazine-1-carbonyl)-1,3-thiazol-2-yl]-2-fluorobenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V013-5057
N-[4-(4-acetylpiperazine-1-carbonyl)-1,3-thiazol-2-yl]-2-fluorobenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V013-5057

Molecular Formula

C17H17FN4O3S (C17 H17 FN4 O3 S)

Compound Name

N-[4-(4-acetylpiperazine-1-carbonyl)-1,3-thiazol-2-yl]-2-fluorobenzamide

IUPAC name

N-[4-(4-acetylpiperazine-1-carbonyl)-13-thiazol-2-yl]-2-fluorobenzamide

SMILES

CC(N(CC1)CCN1C(c1csc(NC(c(cccc2)c2F)=O)n1)=O)=O

InChI

InChI=1S/C17H17FN4O3S/c1-11(23)21-6-8-22(9-7-21)16(25)14-10-26-17(19-14)20-15(24)12-4-2-3-5-13(12)18/h2-5,10H,6-9H2,1H3,(H,19,20,24)

InChI Key

SARYZGIBTCVIJC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19976451

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

376.41

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.713

Distribution Coefficient, logD

1.388

Water Solubility, LogSw

-2.70

Polar Surface Area

67.220

Acid Dissociation Constant (pKa)

7.35

Base Dissociation Constant (pKb)

-2.28

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

29.40

V013-5057 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases
  • Proteases
  • Kinases

References: we are preparing a list of scientific research reports with V013-5057 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V013-5057?
Check Price and Availability of V013-5057, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V013-5057 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V013-5057
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V013-5057
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V013-5057 available by request